The SalivaDirect team at the Yale School of Public Health have designated CLEAR Molecular as an authorized laboratory to offer the SalivaDirect™ test under our EUA.
SalivaDirect is a new process developed at the Yale School of Public Health to test persons suspected of having COVID-19 for the virus, SARS-CoV-2. It is ideal for large-scale testing and offers a number of advantages over traditional testing methods.
SalivaDirect was issued an Emergency Use Authorization (EUA) from the US Food and Drug Administration on August 15, 2020.
PCR TESTING- : “PCR” is shorthand for “polymerase chain reaction,” is considered the “gold standard” in SARS-CoV-2 detection. This test actually detects RNA (or genetic material) that is specific to the virus and can detect the virus within days of infection, even those who have no symptoms.
PCR Test collection options include Nasal Swab and less invasive Saliva PCR Testing.
All test results will be reported within 24 - 48 hours. We offer web based results, auto fax results, as well as direct to employee text messaging. We work with our clients streamlining reporting to assure accurate timely results.
We work with healthcare providers, employers, schools, and municipalities that require testing to provide timely results using the gold standard PCR Testing.
Our laboratory consultants work to customize solutions to assure rapid and timely results in a method that assures effciency.
Saliva PCR Testing- PCR accuracy without the discomfort of a nasal swab. Well suited for workforce and school testing. Convenient and comfortable PCR testing option.
The information contained in this transmission, including attachments, is protected by HIPAA law and is considered confidential.
Copyright © 2020 CLEAR Molecular